{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:12:18Z","timestamp":1788480738612,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate the factors associated with variant histology (VH) and prognostic significance of VH in urothelial carcinoma (UC) among patients undergoing radical cystectomy (RC) with ileal conduit urinary diversion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 317 patients who underwent RC with ileal conduit diversion between 2019 and 2025. Patients were categorized based on the presence of VH in the final pathology. Demographic, clinical, perioperative, and pathological data were compared. Logistic regression was performed to identify factors associated with VH, while Kaplan\u2013Meier and uni-multivariable Cox regression analyses evaluated overall survival (OS) and cancer-specific survival (CSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      VH was detected in 139 patients (43.8%), with squamous differentiation being the most prevalent variant, observed in 80 patients of the 317 patients who underwent RC with ileal conduit urinary diversion. Presence of hydronephrosis, clinical lymph node positivity and WBC\u2009&gt;\u20097695\u00a0g\/dl were defined as factors associated with VH in multivariate logistic regression analysis. Kaplan\u2013Meier survival analysis illustrated a statistically significant reduction in OS and CSS among patients harboring VH compared to those with pure UC following RC and ileal conduit urinary diversion (53.8 vs. 36.8 months for OS and 68 vs. 53 months for CSS, log-rank test,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Multivariable Cox regression analysis revealed that presence of variant histology was associated with reduced OS (HR\u2009=\u20091.624; 95% CI\u2009=\u20091.094\u20132.411;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) and CSS (HR\u2009=\u20091.945; 95% CI\u2009=\u20091.043\u20133.626;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VH in UC is associated with advanced disease and poorer survival outcomes following RC. Certain preoperative factors\u2014hydronephrosis, clinical lymphadenopathy, and elevated WBC\u2014may be associated with the presence of VH. Early recognition of these features could guide individualized treatment strategies and improve prognostic assessment. However, the retrospective and single-center nature of this study may introduce selection and information bias, and the findings should be interpreted with caution until validated by prospective multicenter trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-026-02232-z","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T05:14:03Z","timestamp":1782191643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Variant histology in urothelial carcinoma: associated factors and survival impact after radical cystectomy"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-2122","authenticated-orcid":false,"given":"Emre","family":"Uzun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7648-6603","authenticated-orcid":false,"given":"Serkan","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2280-4192","authenticated-orcid":false,"given":"Samet","family":"Senel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0138-9092","authenticated-orcid":false,"given":"Hasan Batuhan","family":"Arabaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-4840","authenticated-orcid":false,"given":"Antonios","family":"Koudonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2763-0777","authenticated-orcid":false,"given":"Huseyin","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4729-0100","authenticated-orcid":false,"given":"Yalcin","family":"Kizilkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-1291","authenticated-orcid":false,"given":"Cavit","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0101-6904","authenticated-orcid":false,"given":"Cuneyt","family":"Ozden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"2232_CR1","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00345-024-04949-8","volume":"42","author":"A W\u00e9ber","year":"2024","unstructured":"W\u00e9ber A, Vignat J, Shah R, et al. Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol. 2024;42(1):237. https:\/\/doi.org\/10.1007\/s00345-024-04949-8.","journal-title":"World J Urol"},{"issue":"4","key":"2232_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00345-021-03831-1","volume":"40","author":"E Comp\u00e9rat","year":"2022","unstructured":"Comp\u00e9rat E, Oszwald A, Wasinger G, et al. Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies. World J Urol. 2022;40(4):915\u201327. https:\/\/doi.org\/10.1007\/s00345-021-03831-1.","journal-title":"World J Urol"},{"issue":"2","key":"2232_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/BLC-190257","volume":"6","author":"M Alderson","year":"2020","unstructured":"Alderson M, Grivas P, Milowsky MI, Wobker SE. Histologic variants of urothelial carcinoma: morphology, molecular features and clinical implications. Bladder Cancer. 2020;6(2):107\u201322. https:\/\/doi.org\/10.3233\/BLC-190257.","journal-title":"Bladder Cancer"},{"issue":"5","key":"2232_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00428-021-03264-6","volume":"480","author":"A Lopez-Beltran","year":"2022","unstructured":"Lopez-Beltran A, Blanca A, Cimadamore A, et al. T1 bladder carcinoma with variant histology: pathological features and clinical significance. Virchows Arch. 2022;480(5):989\u201398. https:\/\/doi.org\/10.1007\/s00428-021-03264-6.","journal-title":"Virchows Arch"},{"issue":"10","key":"2232_CR5","doi-asserted-by":"publisher","first-page":"6565","DOI":"10.21037\/tcr-20-2169","volume":"9","author":"AJ Black","year":"2009","unstructured":"Black AJ, Black PC. Variant histology in bladder cancer: diagnostic and clinical implications. Transl Cancer Res. 2009;9(10):6565\u201375. https:\/\/doi.org\/10.21037\/tcr-20-2169.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"2232_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21037\/tau-22-43","volume":"11","author":"O Ogbue","year":"2022","unstructured":"Ogbue O, Haddad A, Almassi N, Lapinski J, Daw H. Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes. Transl Androl Urol. 2022;11(6):877\u2013901. https:\/\/doi.org\/10.21037\/tau-22-43.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"2232_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clgc.2020.06.004","volume":"19","author":"RW Speir","year":"2021","unstructured":"Speir RW, Barboza MP, Calaway A, et al. Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter? Clin Genitourin Cancer. 2021;19(1):47\u201352. https:\/\/doi.org\/10.1016\/j.clgc.2020.06.004.","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"2232_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, Shariat SF, Guo CC, et al. What Is the Significance of Variant Histology in Urothelial Carcinoma? Eur Urol Focus. 2020;6(4):653\u201363. https:\/\/doi.org\/10.1016\/j.euf.2019.09.003.","journal-title":"Eur Urol Focus"},{"issue":"2","key":"2232_CR9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euf.2021.04.005","volume":"8","author":"C Lonati","year":"2022","unstructured":"Lonati C, Baumeister P, Ornaghi PI, et al. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy. Eur Urol Focus. 2022;8(2):457\u201364. https:\/\/doi.org\/10.1016\/j.euf.2021.04.005.","journal-title":"Eur Urol Focus"},{"issue":"2","key":"2232_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae.","journal-title":"Ann Surg"},{"issue":"5","key":"2232_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5858\/arpa.2017-0539-RA","volume":"143","author":"G Wang","year":"2019","unstructured":"Wang G, McKenney JK. Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging Update. Arch Pathol Lab Med. 2019;143(5):571\u20137. https:\/\/doi.org\/10.5858\/arpa.2017-0539-RA.","journal-title":"Arch Pathol Lab Med"},{"key":"2232_CR12","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C, editors. TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley-Blackwell; 2017. p. 272. ISBN: 978-1-119-26356-2.","DOI":"10.1002\/9780471420194.tnmc23.pub3"},{"issue":"6","key":"2232_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","volume":"204","author":"K Mori","year":"2020","unstructured":"Mori K, Abufaraj M, Mostafaei H, et al. A Systematic Review and Meta-Analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. J Urol. 2020;204(6):1129\u201340. https:\/\/doi.org\/10.1097\/JU.0000000000001305.","journal-title":"J Urol"},{"issue":"6","key":"2232_CR14","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00345-020-03364-z","volume":"39","author":"R Naspro","year":"2021","unstructured":"Naspro R, Finati M, Roscigno M, et al. The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre. World J Urol. 2021;39(6):1917\u201326. https:\/\/doi.org\/10.1007\/s00345-020-03364-z.","journal-title":"World J Urol"},{"issue":"4","key":"2232_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.21873\/cdp.10046","volume":"1","author":"A Minato","year":"2021","unstructured":"Minato A, Noguchi H, Moriya R, et al. Evaluation of the Extent of Variant Histology in Urothelial Carcinoma as a Predictive Marker of Clinical Outcomes After Radical Cystectomy. Cancer Diagn Progn. 2021;1(4):345\u201351. https:\/\/doi.org\/10.21873\/cdp.10046.","journal-title":"Cancer Diagn Progn"},{"issue":"3","key":"2232_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.22465\/juo.234600400020","volume":"21","author":"DB Lee","year":"2023","unstructured":"Lee DB, Kim JY, Lee YH, et al. Clinical outcomes of patients with variant histology of urothelial carcinoma after radical cystectomy. J Urol Oncol. 2023;21(3):249\u201356. https:\/\/doi.org\/10.22465\/juo.234600400020.","journal-title":"J Urol Oncol"},{"issue":"10","key":"2232_CR17","doi-asserted-by":"publisher","first-page":"8841","DOI":"10.3390\/curroncol30100638","volume":"30","author":"N Prijovic","year":"2023","unstructured":"Prijovic N, Acimovic M, Santric V, et al. The Impact of Variant Histology in Patients with Urothelial Carcinoma Treated with Radical Cystectomy: Can We Predict the Presence of Variant Histology? Curr Oncol. 2023;30(10):8841\u201352. https:\/\/doi.org\/10.3390\/curroncol30100638.","journal-title":"Curr Oncol"},{"issue":"12","key":"2232_CR18","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00345-021-03740-3","volume":"39","author":"S Katayama","year":"2021","unstructured":"Katayama S, Mori K, Pradere B, et al. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer. World J Urol. 2021;39(12):4355\u201361. https:\/\/doi.org\/10.1007\/s00345-021-03740-3.","journal-title":"World J Urol"},{"issue":"4","key":"2232_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.clgc.2023.01.008","volume":"21","author":"M von Deimling","year":"2023","unstructured":"von Deimling M, Schuettfort VM, D\u2019Andrea D, et al. Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy. Clin Genitourin Cancer. 2023;21(4):430\u201341. https:\/\/doi.org\/10.1016\/j.clgc.2023.01.008.","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"2232_CR20","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3390\/medicina60122103","volume":"60","author":"E De\u011ferli","year":"2024","unstructured":"De\u011ferli E, Arslan \u00c7, Sel\u00e7ukbiricik F, et al. Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Med (Kaunas). 2024;60(12):2103. https:\/\/doi.org\/10.3390\/medicina60122103.","journal-title":"Med (Kaunas)"},{"issue":"5","key":"2232_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000539181","volume":"108","author":"N Pyrgidis","year":"2024","unstructured":"Pyrgidis N, Schulz GB, Volz Y, et al. The Prognostic Value of Perioperative Platelet and Leukocyte Values in Patients Undergoing Radical Cystectomy: A Prospective Long-Term Cohort Study. Urol Int. 2024;108(5):421\u20138. https:\/\/doi.org\/10.1159\/000539181.","journal-title":"Urol Int"},{"issue":"3","key":"2232_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/cancers14030536","volume":"14","author":"I Ozel","year":"2022","unstructured":"Ozel I, Duerig I, Domnich M, Lang S, Pylaeva E, Jablonska J. The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. Cancers (Basel). 2022;14(3):536. https:\/\/doi.org\/10.3390\/cancers14030536.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2232_CR23","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.7150\/ijbs.103458","volume":"21","author":"X Li","year":"2025","unstructured":"Li X, Liu X, Wei H, Liu Y, Xu G. Neutrophils in tumor- and inflammation-induced lymphangiogenesis. Int J Biol Sci. 2025;21(5):2223\u201334. https:\/\/doi.org\/10.7150\/ijbs.103458.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"2232_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clgc.2021.12.011","volume":"20","author":"M Laymon","year":"2022","unstructured":"Laymon M, Mosbah A, Hashem A, et al. Oncologic Outcomes of Squamous Cell Carcinoma Versus Urothelial Carcinoma With Squamous Differentiation After Radical Cystectomy for Bladder Carcinoma. Clin Genitourin Cancer. 2022;20(2):148\u201354. https:\/\/doi.org\/10.1016\/j.clgc.2021.12.011.","journal-title":"Clin Genitourin Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02232-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:18Z","timestamp":1788477558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02232-z","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in accordance with the principles of Helsinki Declaration and was approved by the Clinical Research Ethics Committee of Ankara City Hospital (approval number: TABED 1-25-1512). All methods were performed in accordance with the Declaration of Helsinki, relevant guidelines and regulations. The requirement for informed consent to participate was waived by the Clinical Research Ethics Committee of Ankara City Hospital because of the retrospective study design and the use of routinely collected anonymized data, in accordance with national regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"213"}}